Clinical Impact of New Data From AASLD 2019

Source: 2019 Annual Meeting of the American Association for the Study of Liver Diseases*
Download Slideset
November 8-12, 2019; Boston, Massachusetts
This downloadable slideset reviews new, clinically relevant data on viral hepatitis and NAFLD/NASH; topics include risk of HCC in patients with viral hepatitis, HBV and HCV treatment, organ transplant from donors with HCV infection, and novel treatments for NAFLD/NASH.
Ira M. Jacobson, MD
Nancy Reau, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 894 KB
Released: December 2, 2019

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings